Encompass Health Corporation (NYSE:EHC) Shares Bought by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC raised its position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 2.3% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 169,733 shares of the company's stock after purchasing an additional 3,839 shares during the quarter. Segall Bryant & Hamill LLC owned 0.17% of Encompass Health worth $17,191,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in EHC. Signaturefd LLC raised its holdings in shares of Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after acquiring an additional 125 shares in the last quarter. Arlington Trust Co LLC grew its position in shares of Encompass Health by 22.9% during the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock worth $68,000 after buying an additional 125 shares in the last quarter. Merit Financial Group LLC grew its position in shares of Encompass Health by 4.1% during the 1st quarter. Merit Financial Group LLC now owns 4,220 shares of the company's stock worth $427,000 after buying an additional 166 shares in the last quarter. Sequoia Financial Advisors LLC grew its stake in Encompass Health by 6.7% in the first quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock valued at $276,000 after purchasing an additional 172 shares during the last quarter. Finally, Xponance Inc. grew its stake in Encompass Health by 1.6% in the first quarter. Xponance Inc. now owns 11,604 shares of the company's stock valued at $1,175,000 after purchasing an additional 187 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Stock Down 0.3%

Shares of NYSE:EHC traded down $0.30 on Friday, hitting $110.06. 616,437 shares of the company's stock were exchanged, compared to its average volume of 732,520. The firm's 50-day moving average is $119.05 and its 200 day moving average is $106.82. The company has a market capitalization of $11.09 billion, a PE ratio of 22.74, a P/E/G ratio of 2.24 and a beta of 0.88. Encompass Health Corporation has a 1-year low of $82.74 and a 1-year high of $123.13. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.06 and a current ratio of 1.06.

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.18. The business had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The business's quarterly revenue was up 10.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.12 EPS. Sell-side analysts predict that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st were issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.62%. The ex-dividend date was Tuesday, July 1st. Encompass Health's dividend payout ratio is currently 14.05%.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, EVP John Patrick Darby sold 10,000 shares of the stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the transaction, the executive vice president owned 79,710 shares of the company's stock, valued at $9,149,910.90. This represents a 11.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the completion of the transaction, the insider directly owned 11,958 shares in the company, valued at $1,394,422.38. This trade represents a 26.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 132,663 shares of company stock worth $16,034,082. 2.00% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on EHC shares. Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target for the company in a research note on Thursday, June 5th. Truist Financial reissued a "buy" rating and issued a $135.00 price objective (up from $116.00) on shares of Encompass Health in a report on Monday, April 28th. Barclays lifted their price target on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research note on Friday, April 25th. KeyCorp lifted their price target on Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 27th. Finally, UBS Group lifted their price objective on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Seven investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Buy" and an average price target of $131.50.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.